Weaknesses out of strength: PNA against the penicillin-binding proteins
Abstract
According to the World Health Organization (WHO), diarrheal illnesses affect approximately 550 million people annually, including 220 million children under the age of 5 years. The non-typhoidal Salmonella is among the four major global causes of such illnesses and, due to its adaptability to frequently used drugs, is considered a high-priority drug-resistant pathogen.1 Therefore, there is a pressing need to develop novel antibacterial strategies targeting Salmonella infections. A recent study, published in Molecular Therapy Nucleic Acids by El-Fateh et al., describes the elimination of Salmonella spp.
Fields of Study & Subjects
RNA Interference and Gene Delivery
Bacterial Genetics and Biotechnology
DNA and Nucleic Acid Chemistry
Publication details
- Journal / source
- Molecular Therapy — Nucleic Acids
- Volume
- 37
- Issue
- 1
- Pages
- 102828–102828
- Publication date
- 19 January 2026
- Language
- EN